Pluristyx
Healthcare & Life Sciences
Recent Finacing
Equity
Recent Raise
Undisclosed
Pluristyx is a company that provides gene-edited induced pluripotent stem cell (iPSC) lines and cell therapy development tools and services to accelerate the clinical trial and commercialization process for stem cell therapeutic companies.
Focus Areas
cell therapy development
cGMP cell line services
panCELLa platform
stem cell therapeutics
gene-edited iPSC
clinical trials
Investors
